Trump, Trudeau discuss trade, economic issues over phone call
June 30, 2018GM says U.S. import tariffs could mean ‘smaller’ company, fewer jobs
June 30, 2018Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft
at
ZURICH (Reuters) – The chairman of Swiss drugmaker Novartis expects Alcon to be valued at between $20 billion and $30 billion when the opthalmic devices unit is spun off to shareholders next year, he said in an interview with Finanz und Wirtschaft.
Powered by WPeMatico
